Company intelligence / Profile preview

Qi Diagnostics

Hong Kong, Hong Kong

Ownership: Private
Development stage: Other

Overview

Qi Diagnostics is developing a non-invasive breath test instrument for lung cancer detection based on proprietary VOC nanosensor technology. The device aims to provide real-time, radiation-free, and cost-effective screening to enable earlier cancer diagnosis. Clinical trials and certification are targeted within the next two years.

Therapeutic areas: Oncology
Modalities: Device
Industry: Metabolite Diagnostics

Beyond the preview

Go deeper on Qi Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qi Diagnostics.

Explore the full profile